Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 04 Jan 2023 for Oramed Pharmaceuticals INC., €17k. Read the official filing
Filing timeline
BuySaleMichael Rabinowitz
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Michael Rabinowitz: trading record in brief
Michael Rabinowitz appears in our data through filings on Oramed Pharmaceuticals Inc. shares, published by SEC (Form 4). Between 4 August 2021 and 3 January 2023, the trades on record add up to 5 filings.
Sales make up the whole of the open-market record (1 sale, €17k). Outside the open market, there are 4 share grants. 2023 to date brings no purchases and 1 sale.
The latest filing, published on 4 January 2023, reports an open-market sale of €17k in Oramed Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael Rabinowitz
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
1,425 shares@ US$13.013213.7% of flowCommon StockSEC:0001209191-23-000517:0
30,000 sharesCommon StockSEC:0001209191-22-043764:0
19,000 sharesCommon StockSEC:0001213900-22-000814:0
9,532 shares@ US$12.9886.3% of flowCommon StockSEC:0001213900-21-068230:0
100,000 shares0Common StockSEC:0001213900-21-040761:0
5 of 5 declarations
